Elmwood Park, IL, United States of America

Arun K Sharma

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Oak Park, IL (US) (2005 - 2009)
  • Elmwood Park, IL (US) (2011 - 2024)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arun K Sharma

Introduction

Arun K Sharma is a notable inventor based in Elmwood Park, IL, with a significant portfolio of seven patents. His work primarily focuses on advancements in medical treatments, particularly in the field of inflammatory bowel diseases.

Latest Patents

Among his latest patents, Sharma has developed nanomolecules aimed at treating inflammatory bowel diseases. One of his key inventions includes anti-inflammatory peptide amphiphiles (AIF-PAs) and their methods of use. These innovations involve the creation of nanofibers from AIF-PAs, which are designed to treat conditions such as Crohn's disease. Additionally, he has patented anti-inflammatory nanofibers that promote tissue regeneration, specifically targeting urinary bladder tissue.

Career Highlights

Sharma has had a distinguished career, contributing to significant research and development in his field. He has worked with prestigious institutions such as Northwestern University and the University of Illinois, where he has made impactful contributions to medical science.

Collaborations

Some of his notable coworkers include Ronald Hoffman and Sherman Elias, who have collaborated with him on various projects.

Conclusion

Arun K Sharma's innovative work in the development of nanomolecules and anti-inflammatory treatments showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of inflammatory bowel diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…